Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Transplantation

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    January 2019
  1. TAYLOR R, Allen E, Richards JA, Goh AM, et al
    Survival advantage for patients accepting the offer of a circulatory death liver transplant.
    J Hepatol. 2019 Jan 10. pii: S0168-8278(19)30010.
    PubMed     Text format     Abstract available


  2. GOLDARACENA N, Gorgen A, Doyle A, Hansen BE, et al
    Live Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Offers Increased Survival vs. Deceased Donation.
    J Hepatol. 2019 Jan 7. pii: S0168-8278(19)30003.
    PubMed     Text format     Abstract available


    December 2018
  3. HESSHEIMER AJ, Coll E, Torres F, Ruiz P, et al
    Normothermic regional perfusion versus super rapid recovery in controlled donation after circulatory death liver transplantation.
    J Hepatol. 2018 Dec 21. pii: S0168-8278(18)32632.
    PubMed     Text format     Abstract available


  4. DURAND F, Levitsky J, Cauchy F, Gilgenkrantz H, et al
    Age and Liver Transplantation.
    J Hepatol. 2018 Dec 18. pii: S0168-8278(18)32626.
    PubMed     Text format     Abstract available


  5. ICHAI P, Laurent-Bellue A, Camus C, Moreau D, et al
    Liver transplantation in patients with liver failure related to exertional heatstroke.
    J Hepatol. 2018 Dec 3. pii: S0168-8278(18)32575.
    PubMed     Text format     Abstract available


    November 2018
  6. DE MEIJER VE, Fujiyoshi M, Porte RJ
    Ex situ machine perfusion strategies in liver transplantation.
    J Hepatol. 2018 Nov 5. pii: S0168-8278(18)32436.
    PubMed     Text format    


  7. ROY A, Taneja S
    Type of organ failure and acute insult have important bearings in outcomes of liver transplantation: A pragmatic discourse.
    J Hepatol. 2018 Nov 3. pii: S0168-8278(18)32384.
    PubMed     Text format    


  8. THULUVATH PJ, Thuluvath AJ, Hanish S, Savva Y, et al
    Reply to: "Type of organ failure and acute insult have important bearings in outcomes of liver transplantation: A pragmatic discourse".
    J Hepatol. 2018 Nov 2. pii: S0168-8278(18)32496.
    PubMed     Text format    


    October 2018
  9. SCHLEGEL A, Muller X, Kalisvaart M, Muellhaupt B, et al
    Outcomes of liver transplantations from donation after circulatory death (DCD) treated by hypothermic oxygenated perfusion (HOPE) before implantation.
    J Hepatol. 2018 Oct 17. pii: S0168-8278(18)32457.
    PubMed     Text format     Abstract available


  10. O'BRIEN A, Kamath PS, Trotter J
    MACHT - Outpatient albumin infusions do not prevent complications of cirrhosis in patients on the liver transplant waiting list.
    J Hepatol. 2018 Oct 9. pii: S0168-8278(18)32444.
    PubMed     Text format    


  11. BERENGUER M, de la Rosa Rodriguez G, Dominguez-Gil B
    Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.
    J Hepatol. 2018;69:966-968.
    PubMed     Text format    


    September 2018
  12. FERNANDEZ J, Saliba F
    Liver transplantation in patients with ACLF and multiple organ failure: Time for priority after initial stabilization.
    J Hepatol. 2018 Sep 18. pii: S0168-8278(18)32372.
    PubMed     Text format    


    August 2018
  13. SOLA E, Sole C, Simon-Talero M, Martin-Llahi M, et al
    MIDODRINE &ALBUMIN for Preventing COMPLICATIONS IN PATIENTS WITH CIRRHOSIS AWAITING Liver transplantation.
    J Hepatol. 2018 Aug 20. pii: S0168-8278(18)32285.
    PubMed     Text format     Abstract available


  14. TERRAULT NA, Pageaux GP
    A changing landscape of liver transplantation: King HCV is dethroned, ALD and NAFLD take over!
    J Hepatol. 2018 Aug 10. pii: S0168-8278(18)32276.
    PubMed     Text format    


  15. ASRANI SK, Saracino G, O'Leary JG, Gonzalez S, et al
    Corrigendum to "Recipient characteristics and morbidity and mortality after liver transplantation" [J hepatol 69 (2018) 43-50].
    J Hepatol. 2018 Aug 7. pii: S0168-8278(18)32268.
    PubMed     Text format    


  16. HERZER K, Gerken G, Kroy D, Tacke F, et al
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany.
    J Hepatol. 2018 Aug 6. pii: S0168-8278(18)32179.
    PubMed     Text format    


    July 2018
  17. THULUVATH PJ, Thuluvath AJ, Hanish S, Savva Y, et al
    Liver Transplantation in Patients with Multiple Organ Failures: Feasibility and Outcomes.
    J Hepatol. 2018 Jul 30. pii: S0168-8278(18)32259.
    PubMed     Text format     Abstract available


  18. LAUTERIO A, Moioli MC, Di Sandro S, Travi G, et al
    HIV-positive to HIV-positive liver transplantation: To be continued.
    J Hepatol. 2018 Jul 23. pii: S0168-8278(18)32180.
    PubMed     Text format    


  19. OLDANI G, Peloso A, Vijgen S, Wilson EM, et al
    Chimeric liver transplantation reveals interspecific graft remodelling.
    J Hepatol. 2018 Jul 19. pii: S0168-8278(18)32260.
    PubMed     Text format     Abstract available


    June 2018
  20. HUTCHINSON JA, Schlitt HJ
    Subclinical T cell-mediated liver transplant rejection: The jury is still out.
    J Hepatol. 2018 Jun 30. pii: S0168-8278(18)32157.
    PubMed     Text format    


  21. BELLI LS, Perricone G, Adam R, Cortesi PA, et al
    Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.
    J Hepatol. 2018 Jun 22. pii: S0168-8278(18)32163.
    PubMed     Text format     Abstract available


  22. BRINKERT F, Pukite I, Krebs-Schmitt D, Briem-Richter A, et al
    Allogeneic hematopoietic stem cell transplantation eliminates alloreactive inhibitory antibodies after liver transplantation for bile salt export pump deficiency.
    J Hepatol. 2018 Jun 20. pii: S0168-8278(18)32156.
    PubMed     Text format     Abstract available


  23. AGARWAL K, Castells L, Mullhaupt B, Rosenberg WMC, et al
    Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients.
    J Hepatol. 2018 Jun 7. pii: S0168-8278(18)32124.
    PubMed     Text format     Abstract available


  24. THULUVATH PJ, Thuluvath AJ, Savva Y
    Karnofsky Performance Status Before and After Liver Transplantation Predicts Graft and Patient Survival.
    J Hepatol. 2018 Jun 5. pii: S0168-8278(18)32110.
    PubMed     Text format     Abstract available


    April 2018
  25. LONDONO MC, Souza LN, Lozano JJ, Miquel R, et al
    Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients.
    J Hepatol. 2018 Apr 27. pii: S0168-8278(18)32022.
    PubMed     Text format     Abstract available


  26. SCHLEGEL A, Kalisvaart M, Isaac J, Muiesan P, et al
    Reply to: DCD consensus and futility in Liver Transplantation.
    J Hepatol. 2018 Apr 13. pii: S0168-8278(18)31977.
    PubMed     Text format    


  27. GIORGAKIS E, Khorsandi SE, Jassem W, Heaton N, et al
    "DCD consensus and futility in Liver Transplantation".
    J Hepatol. 2018 Apr 12. pii: S0168-8278(18)31976.
    PubMed     Text format    


    March 2018
  28. MATHUR AK, Talwalkar J
    Quality measurement and improvement in liver transplantation.
    J Hepatol. 2018 Mar 17. pii: S0168-8278(18)30173.
    PubMed     Text format     Abstract available


  29. SCHLEGEL A, Kalisvaart M, Isaac J, Dutkowski P, et al
    Reply to: Redefining futility in DCD liver transplantation in the era of novel perfusion technologies.
    J Hepatol. 2018 Mar 14. pii: S0168-8278(18)30153.
    PubMed     Text format    


  30. ONISCU GC, Watson CJE, Wigmore SJ
    Redefining futility in DCD liver transplantation in the era of novel perfusion technologies.
    J Hepatol. 2018 Mar 14. pii: S0168-8278(18)30152.
    PubMed     Text format    


  31. LUTHER J, Dienstag JL
    Reply: Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30141.
    PubMed     Text format    


  32. DELTENRE P, Marot A, Dubois M, Trepo E, et al
    Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30142.
    PubMed     Text format    


    February 2018
  33. CRESPO G, Trota N, Londono MC, Mauro E, et al
    The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in wait-list composition.
    J Hepatol. 2018 Feb 23. pii: S0168-8278(18)30129.
    PubMed     Text format     Abstract available


  34. ASRANI SK, Saracino G, O'Leary JG, Gonzales S, et al
    Recipient characteristics and morbidity and mortality after liver transplantation.
    J Hepatol. 2018 Feb 14. pii: S0168-8278(18)30120.
    PubMed     Text format     Abstract available


  35. YOON YI, Song GW, Lee SG, Hwang S, et al
    Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    J Hepatol. 2018 Feb 13. pii: S0168-8278(18)30113.
    PubMed     Text format     Abstract available


  36. KIM AY, Sinn DH, Jeong WK, Kim YK, et al
    Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
    J Hepatol. 2018 Feb 2. pii: S0168-8278(18)30071.
    PubMed     Text format     Abstract available


    December 2017
  37. VAN VUGT JLA, Alferink LJM, Buettner S, Gaspersz MP, et al
    A Model including Sarcopenia Surpasses the MELD Score in Predicting Waiting List Mortality in Cirrhotic Liver Transplant Candidates.
    J Hepatol. 2017 Dec 5. pii: S0168-8278(17)32474.
    PubMed     Text format     Abstract available


  38. O'GRADY JG
    Relaxing Access to Liver Transplantation with Living Donation: A Foolish Move or a Time to Change?
    J Hepatol. 2017 Dec 2. pii: S0168-8278(17)32477.
    PubMed     Text format    


    November 2017
  39. FAITOT F, Besch C, Battini S, Ruhland E, et al
    Impact of real-time metabolomics in liver transplantation: graft evaluation and donor-recipient matching.
    J Hepatol. 2017 Nov 27. pii: S0168-8278(17)32447.
    PubMed     Text format     Abstract available


  40. KUBILIUN M, Patel SJ, Hur C, Dienstag JL, et al
    Early liver transplantation for alcoholic hepatitis: Ready for primetime?
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32452.
    PubMed     Text format    


  41. SCHLEGEL A, Kalisvaart M, Scalera I, Laing RW, et al
    The UK-DCD-Risk-Score: a new proposal to define futility in Donation after Circulatory Death liver transplantation.
    J Hepatol. 2017 Nov 15. pii: S0168-8278(17)32432.
    PubMed     Text format     Abstract available


  42. LINECKER M, Krones T, Berg T, Niemann CU, et al
    Potentially Inappropriate Liver Transplantation in the Era of the "Sickest-first" Policy - A Search for the Upper Limits.
    J Hepatol. 2017 Nov 10. pii: S0168-8278(17)32430.
    PubMed     Text format     Abstract available


    October 2017
  43. CHOUDHARY NS, Saraf N, Soin AS
    Liver Transplantation for Grade 3 Acute on Chronic Liver Failure: Type of Organ Failure is Important.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32401.
    PubMed     Text format    


  44. ARTRU F, Louvet A
    Reply to <<Liver transplantation for grade 3 acute-on-chronic liver failure: type of organ failure is important>>.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32402.
    PubMed     Text format    


  45. LIEBER SR, Schiano TD, Rhodes R
    Should Living Donor Liver Transplantation Be an Option When Deceased Donation Is Not?
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32405.
    PubMed     Text format     Abstract available


  46. LONDONO MC, Forns X, Pascasio JM
    Reply to: "Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations".
    J Hepatol. 2017 Oct 25. pii: S0168-8278(17)32385.
    PubMed     Text format    


  47. AZAB M, Shah S, Liu X, Ukken J, et al
    Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations.
    J Hepatol. 2017 Oct 24. pii: S0168-8278(17)32390.
    PubMed     Text format    


  48. GUSTOT T, Agarwal B
    Selected patients with acute-on-chronic liver failure grade 3 are not too sick to be considered for liver transplantation.
    J Hepatol. 2017;67:667-668.
    PubMed     Text format    


    September 2017
  49. VERHOEVEN CJ, Selten JW, Roest HP, Farid WRR, et al
    Corrigendum to "MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation" [J Hepatol 2013; 59:1231-1238].
    J Hepatol. 2017 Sep 27. pii: S0168-8278(17)32279.
    PubMed     Text format    


  50. LIU X, Shen JJ, Jung Kim S, Lee YJ, et al
    Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation.
    J Hepatol. 2017 Sep 19. pii: S0168-8278(17)32290.
    PubMed     Text format    


    August 2017
  51. SAMUEL D, Sanchez-Fueyo A
    Immunotherapy in liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32049.
    PubMed     Text format    


  52. PASCASIO JM, Vinaixa C, Ferrer MT, Colmenero J, et al
    Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32215.
    PubMed     Text format     Abstract available


  53. RAJAKANNU M, Coilly A, Adam R, Samuel D, et al
    Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation.
    J Hepatol. 2017 Aug 21. pii: S0168-8278(17)32214.
    PubMed     Text format    


  54. KARLSEN TH, Folseraas T, Thorburn D, Vesterhus M, et al
    Primary sclerosing cholangitis - a comprehensive review.
    J Hepatol. 2017 Aug 9. pii: S0168-8278(17)32196.
    PubMed     Text format     Abstract available


    July 2017
  55. TRIVEDI PJ, Scalera I, Slaney E, Laing RW, et al
    Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    J Hepatol. 2017 Jul 6. pii: S0168-8278(17)32135.
    PubMed     Text format     Abstract available


    June 2017
  56. ARTRU F, Louvet A, Ruiz I, Levesque E, et al
    Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3.
    J Hepatol. 2017 Jun 20. pii: S0168-8278(17)32079.
    PubMed     Text format     Abstract available


    May 2017
  57. NADIM MK, DiNorcia J, Ji L, Groshen S, et al
    Inequity In Organ Allocation For Patients Awaiting Liver Transplantation: Rationale for Uncapping the Model for End-Stage Liver Disease.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32003.
    PubMed     Text format     Abstract available


  58. WENDON, J, Cordoba J, Dhawan A, Larsen FS, et al
    EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.
    J Hepatol. 2017;66:1047-1081.
    PubMed     Text format     Abstract available


    April 2017
  59. COLMENERO J, Sancho-Bru P
    Mesenchymal stromal cells for immunomodulatory cell therapy in liver transplantation: one step at a time.
    J Hepatol. 2017 Apr 20. pii: S0168-8278(17)30215.
    PubMed     Text format    


  60. HIRSCHFIELD GM, Beuers U, Corpechot C, Invernizzi P, et al
    EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.
    J Hepatol. 2017 Apr 17. pii: S0168-8278(17)30186.
    PubMed     Text format     Abstract available


  61. SCHWARZINGER M, Baillot S, Yazdanpanah PY, Rehm PJ, et al
    Contribution of Alcohol Use Disorders on the Burden of Chronic Hepatitis C in France, 2008-2013: A Nationwide Retrospective Cohort Study.
    J Hepatol. 2017 Apr 7. pii: S0168-8278(17)30202.
    PubMed     Text format     Abstract available


    March 2017
  62. QURINO L, Massimo R, Jan L
    Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?
    J Hepatol. 2017 Mar 24. pii: S0168-8278(17)30180.
    PubMed     Text format    


  63. BHAT M, Ghali P, Bilodeau M
    Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?"
    J Hepatol. 2017 Mar 24. pii: S0168-8278(17)30183.
    PubMed     Text format    


  64. BELLI LS, Duvoux C, Berg T, Strazzabosco M, et al
    ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
    J Hepatol. 2017 Mar 18. pii: S0168-8278(17)30140.
    PubMed     Text format     Abstract available


  65. DETRY O, Vandermeulen M, Delbouille MH, Somja J, et al
    Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    J Hepatol. 2017 Mar 8. pii: S0168-8278(17)30131.
    PubMed     Text format     Abstract available


  66. BESTE LA, Green PK, Berry K, Kogut MJ, et al
    Effectiveness of hepatitis c antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.
    J Hepatol. 2017 Mar 3. pii: S0168-8278(17)30126.
    PubMed     Text format     Abstract available


    February 2017
  67. SAPISOCHIN G, Barry A, Doherty M, Fischer S, et al
    Stereotactic body radiotherapy versus TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.
    J Hepatol. 2017 Feb 28. pii: S0168-8278(17)30119.
    PubMed     Text format     Abstract available


    November 2016
  68. NOTARPAOLO A, Layese R, Magistri P, Gambato M, et al
    Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    J Hepatol. 2016 Nov 26. pii: S0168-8278(16)30688.
    PubMed     Text format     Abstract available


  69. MALLET V, Hamed K, Schwarzinger M
    Prognosis of Patients with Chronic Hepatitis B in France (2008-2013): A Nationwide, Observational and Hospital-based Study.
    J Hepatol. 2016 Nov 5. pii: S0168-8278(16)30642.
    PubMed     Text format     Abstract available


    October 2016
  70. BHAT M, Ghali P, Dupont B, Hilzenrat R, et al
    Proposal of a Novel MELD Exception Point System for Hepatocellular Carcinoma based on Tumor Characteristics and Dynamics.
    J Hepatol. 2016 Oct 14. pii: S0168-8278(16)30571.
    PubMed     Text format     Abstract available


  71. VAN DER MEER AJ, Berenguer M
    Reversion of disease manifestations after HCV eradication.
    J Hepatol. 2016;65.
    PubMed     Text format     Abstract available


  72. MORADPOUR D, Grakoui A, Manns MP
    Future landscape of hepatitis C research - Basic, translational and clinical perspectives.
    J Hepatol. 2016;65.
    PubMed     Text format     Abstract available


    September 2016
  73. SHIN WJ, Song JG, Jun IG, Moon YJ, et al
    Effect of ventriculo-arterial coupling on transplant outcomes in cirrhotics: Analysis of pressure-volume curve relations.
    J Hepatol. 2016 Sep 26. pii: S0168-8278(16)30536.
    PubMed     Text format     Abstract available


    April 2016
  74. WESTBROOK RH, Dusheiko G, Williamson C
    Pregnancy and liver disease.
    J Hepatol. 2016;64:933-45.
    PubMed     Text format     Abstract available


    January 2016
  75. SCHLEGEL A, Kron P, De Oliveira ML, Clavien PA, et al
    Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?
    J Hepatol. 2016;64:239-41.
    PubMed     Text format    


    September 2015
  76. COILLY A, Samuel D
    Pros and Cons: Usage of organs from donors infected with hepatitis C virus - revision in the direct acting antiviral era.
    J Hepatol. 2015 Sep 12. pii: S0168-8278(15)00617.
    PubMed     Text format     Abstract available


    August 2015
  77. GRANCINI V, Trombetta M, Lunati ME, Zimbalatti D, et al
    Contribution of beta-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease.
    J Hepatol. 2015 Aug 19. pii: S0168-8278(15)00553.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: